DUCATION · Dissertation: Evaluating Legal Interventions Designed to Improve Behavioral Health Outcomes Committee: Michelle Mello (Co-Chair), Alan Zaslavsky (Co-Chair), Frank Wharam,

Do not use for proposals C U R R I C U L U M V I T A E

R E B E C C A L . H A F F A J E E

RAND Corporation

20 Park Plaza, Suite 920, Boston, MA 02116

Tel. (617) 338-2059 x 8653

Email: [email protected]

EDUCATION:

2016

Health Policy

Evaluative Sciences & Statistics Track

Ph.D.

Harvard University

Cambridge, MA

Dissertation: Evaluating Legal Interventions Designed to Improve Behavioral Health Outcomes

Committee: Michelle Mello (Co-Chair), Alan Zaslavsky (Co-Chair), Frank Wharam, Glenn Cohen

2006 Law J.D. Harvard Law School

Cambridge, MA

2006 Law and Public Health M.P.H. Harvard School of Public Health

Cambridge, MA

2002 Women’s Studies Program

Certificate in Health Policy

B.A. Duke University

Durham, NC

LICENSURE AND CERTIFICATION:

2006- Massachusetts State Bar

2009-12 District of Columbia Bar

ACADEMIC APPOINTMENTS:

2016-19 Assistant Professor, Department of Health Management and Policy, University of Michigan

School of Public Health

2019- Adjunct Assistant Professor, Department of Health Management and Policy, University of

Michigan School of Public Health

2019- Policy Researcher, RAND Corporation

HONORS AND DISTINCTIONS:

2018 Theodore R. LeBlang Distinguished Lectureship in Law & Medicine, Southern Illinois University

School of Medicine, Springfield, IL

2017 AcademyHealth Outstanding Dissertation Award at the 2017 Annual Research Meeting, New

Orleans, LA

2017 Walter J. McNerney Research Award, Department of Health Management and Policy, University of

Michigan School of Public Health

2017 Health Policy Grand Rounds Seminar Speaker, Richard M. Fairbanks School of Public Health,

Indiana University

Rebecca L. Haffajee, Page 2

2015 AcademyHealth Student Poster Award at the 2015 Annual Research Meeting, Minneapolis, MN

2015 Joan P. Curhan Citizenship Award for the Ph.D. Program in Health Policy, Harvard University

2013-14 Public Health Law Research Program Strategic and Targeted Research Program Dissertation Grant

Award, Robert Wood Johnson Foundation

2013-14 Health Policy Training Grant Award, National Institute of Mental Health

2013 Public Health Law Research Program Junior Scholar Travel Stipend Award, Robert Wood Johnson

Foundation

2011-12 Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics Student Fellow, Harvard

Law School

2010-12 Ph.D. Program in Health Policy Pre-Doctoral Training Fellowship Award, Harvard University

2009-10 New Alternatives Program Fellow, Ropes & Gray, LLP

2006 Fulbright U.S. Student Program Fellowship Grantee (Public Health – South Africa), United States

Department of State

2006 Frank Knox Memorial Traveling Fellowship Award (Public Health – South Africa), Harvard

University

2004 Summer Public Interest Funding Award (United Nations Criminal Tribunal for Rwanda), Harvard

Law School

2004 Best Female Collegiate Soloist of the Year Contemporary A Cappella Recording Award, 2004, The

Contemporary A Cappella Society

2002-03 Hart Leadership Fellow (Public Health Research – Tanzania), Duke University

2002 Graduation Magna Cum Laude, Duke University

PROFESSIONAL SERVICE AND MEMBERSHIP:

2020-22 External Advisory Council Member, Arnold Ventures/Johns Hopkins Bloomberg School

of Public Health study on the effects of opioid prescription limitation laws on prescribing and health

2019 External Reviewer, Foundation for Opioid Response Efforts (FORE) Grants on “Improving

Access to Opioid Use Disorder Treatment and Recovery Services for Underserved Populations and

Communities”

2019 Faculty Expert, University of Michigan Coursera/edX Massive Open Online Course, “Impacting

the Opioid Crisis: Prevention, Education, and Practice for Non-Prescribing Providers”

2018 Paper Discussant, 13th Annual Conference for Empirical Legal Studies, University of Michigan Law

School, Ann Arbor, MI

2018 Faculty Mentor, Tarlise Townsend and Amanda Mauri, University of Michigan Injury Prevention

Center Summer Fellowship Program

2018-19 Faculty Supervisor, JD/MPH Dual Degree Program, University of Michigan School of Public Health

2017- Faculty Member, Public Health Law Watch: An Initiative of the George Consortium

2017- Faculty Member, Internal Advisory Committee, Injury Prevention Center, University of Michigan

2017-19 Faculty Member, Policy Committee, Injury Prevention Center, University of Michigan

2017 Faculty Expert, Coursera University of Michigan Teach-Out Course, “Solving the Opioid Crisis”

2016-19 Member Expert, Institute for Healthcare Policy and Innovation, University of Michigan

2016-19 Faculty Member, Center for Social Epidemiology and Population Health, University of Michigan

Rebecca L. Haffajee, Page 3

2016- Faculty Member Affiliate, Injury Prevention Center, University of Michigan

2016-19 Faculty Member, Mental Health Innovation, Services and Outcomes Program, University of

Michigan

2016-19 Faculty Member, Health Management and Policy Research Committee, University of Michigan

School of Public Health

2016-17 Faculty Member, Health Management and Policy Executive Master’s Program Committee,

University of Michigan School of Public Health

2016 Paper Discussant, 11th Annual Conference for Empirical Legal Studies, Duke University Law

School, Durham, NC

2016 Content Adviser, Harvard X Course, “The Opioid Crisis in America”

2015- Peer Reviewer: New England Journal of Medicine, JAMA, JAMA Internal Medicine, Health

Affairs, Annals of Internal Medicine, International Journal of Drug Policy, Drug and Alcohol

Dependence, Medical Care, BMJ, BMJ Open, American Journal of Preventive Medicine, American

Journal of Public Health, Journal of Substance Abuse and Treatment, Pediatrics, Western Journal

of Nursing, PLOS One, Journal of Law, Medicine & Ethics.

2014 Public Health Member, Expert Panel for Emergency Medicine Foundation study on identifying key

characteristics for prescription drug monitoring programs for emergency department use

PROFESSIONAL SOCIETIES:

American Society of Law, Medicine & Ethics

American Health Lawyers Association

American Public Health Association

AcademyHealth

Society for Empirical Legal Studies

PROFESSIONAL AND RESEARCH EXPERIENCE:

2011-13 Research Assistant to Dr. Michelle Mello of Harvard School of Public Health on a Robert Wood

Johnson Foundation study of provider “disclosure-and-offer” programs.

2009-10 Law Fellow, O’Neill Institute for National and Global Health Law, Georgetown University,

Washington, DC

2006-09 Health Care Law Associate, Corporate Department, Ropes & Gray, LLP, Boston, MA and

Washington, DC

2006 Legal Intern, Physicians for Human Rights, Cambridge, MA

2003-06 Managing Editor and Article Editor, Harvard Journal of Law and Gender, Harvard Law School,

Cambridge, MA

2005 Summer Associate, Ropes & Gray, LLP, Boston, MA and Washington, DC

2004 Legal Intern, Office of the Prosecutor, United Nations International Criminal Tribunal for Rwanda,

Arusha, Tanzania

2004 Research Assistant to Drs. Michelle Mello and Troyen Brennan of Harvard School of Public Health

on a project related to advertising of junk foods and childhood obesity.

2002-03 Hart Research Fellow on a Duke University study led by Dr. Kathryn Whetten investigating the

socio-cultural impact of HIV/AIDS in northern Tanzania.

1998-02 Music Director and Member, Out of the Blue a cappella singing group, Duke University, Durham,

NC

Rebecca L. Haffajee, Page 4

MAJOR RESEARCH INTERESTS:

1. Empirical analysis of health laws and policies

2. Public health law and interventions

3. Behavioral health policy

4. Pharmaceutical policy

5. Injury prevention

RESEARCH SUPPORT:

CURRENT SUPPORT:

2020-23 Centers for Disease Control & Prevention, University of Michigan Injury Prevention Center Core

Project (Haffajee, Bohnert – Multi-PIs)

The Association between Prescription Opioid Limitation Laws and Suicide Outcomes: Project

examines the relationship between state prescription opioid limitation laws and fatal suicide outcomes

in the U.S. population and nonfatal suicide outcomes (including attempts and ideation) in the

commercially insured population.

(Contact Principal Investigator)

2019-20 Institute for Civil Justice, RAND Corporation (Haffajee, Kilmer, Helland – Multi-PIs)

Opioid Litigation in the U.S.: Evolution, Characteristics, and Outcomes: Project examines the

trajectory of cases filed in the opioid litigation, to understand trends in geographic, party, claim, and

other features of the cases over time. It also examines the association between opioid

morbidity/mortality risk factors and opioid litigation characteristics.

(Contact Principal Investigator)

2019-20 National Institute on Drug Abuse (P50 Supplement, Stein, Pacula – Multi-PIs)

The Opioid Policy, Technology, & Implementation Center for Research Excellence: Opioid

Abatement Strategies: Administrative supplement identifies evidence-based and other promising

emerging policies to prevent opioid misuse and addiction among adults and youth, and to mitigate

harms to children of adults with opioid misuse and addiction. The resulting compendium will serve

as a litigation resource for abatement strategies.

(Co-Investigator)

2019-22 National Institute of Mental Health (R01, Zivin – PI)

Relationship between Mental Health Coverage and Outcomes for Privately Insured Women with

Perinatal Mood and Anxiety Disorders. Project assesses how changes in mental health coverage

under the Mental Health Parity and Addition Equity Act and Patient Protection and Affordable Care

Act affect delivery-related health outcomes, as well as utilization of and spending on mental health-

related and overall health services.

(Co-Investigator)

2019-21 National Institute on Drug Abuse (R21, Heinze – PI)

Understanding Intergenerational Transmission of Drug Use in the Context of Cannabis

Legalization: Study seeks to understand how the intergenerational transmission of the substance use

is affected by Cannabis legalization in an at-risk sample of urban young adults and their children.

(Consultant)

2017-20 Centers for Disease Control & Prevention, National Center for Injury Control and Prevention

(#1U01CE002780-01) (Bohnert, Larochelle – Multi-PIs)

Heroin Use and Overdose Following Changes to Individual-Level Opioid Prescribing: Project

examines whether patients who are tapered from high dosages of opioids are experiencing heroin-

related overdoses in greater numbers than expected, and if so, why this transition to heroin use occurs,

using secondary commercial claims data and qualitative interviews.

(Co-Investigator)

Rebecca L. Haffajee, Page 5

PAST SUPPORT:

2018-19 Health Resources and Services Administration (#U81HP293000400, Beck – PI)

Behavioral Health Workforce Research Center: Center conducts national studies on behavioral health

workforce. Led projects on workforce provider roles/opportunities in treating opioid use disorder.

(Co-Investigator)

2017-19 National Center for Advancing Translational Sciences of the National Institutes of Health, Michigan

Institute for Clinical and Health Research (#KL2TR002241) (Haffajee – PI) $391,614

Differential Prescription Drug Monitoring Program Effects across Specialties and Patient

Populations: Career development award allowed study of prescription drug monitoring and other

opioid policy impacts across patient and prescriber populations using secondary data analysis.

(Principal Investigator)

2018-19 Michigan Department of Health and Human Services, Prescription Drug Overdose Prevention

Initiative

Prescription Drug Monitoring Program and Opioid Policy Evaluation: Project examines, using

administrative claims data, opioid prescribing measures in Michigan, relative to upgrades to the

Michigan Automated Prescription System (MAPS). Consult regarding state evaluations of naloxone

distribution laws and other opioid policies.

(Consultant)

2018-19 Centers for Disease Control & Prevention, University of Michigan Injury Center Core Project (#CDC

3R49CE002099-05S1) (Bohnert, Maust – Multi-PIs)

The Effect of a Prescription Drug Coverage Policy on Risk of Falls and Overdose in Older Adults:

Project examines the effect of Medicare coverage policy changes for benzodiazepines on the rate of

fall-related injuries and unintentional overdose among elderly individuals in Medicare advantage

plans, including those prescribed opioid analgesics.

(Co-Investigator)

2018-19 Laura and John Arnold Foundation (Frank – PI)

Generic Drug Policy and Opioid Disorder Treatment: Project investigates naloxone and

buprenorphine pricing trends and generic drug policy to elucidate market and regulatory factors that

affect the availability of opioid disorder treatments.

(Consultant)

2017-18 Walter J. McNerney Award, Department of Health Management and Policy, University of Michigan

School of Public Health (Haffajee – PI)

Opioid Prescriber Responses to Opioid Prescribing Prevention Policies: Project surveys a nationally

representative sample of physicians across four high-volume opioid prescriber specialties to

understand their knowledge and perception of, and behavior changes in response to, key national-,

state-, and provider-level opioid prescribing prevention policies.

(Principal Investigator)

2017-18 Centers for Disease Control & Prevention, National Center for Injury Control and Prevention (CDC

3R49CE002099-05S1) (Cunningham – PI)

University of Michigan Injury Prevention Center: The mission of the University of Michigan Injury

Prevention Center is to conduct high-quality injury research and training, to translate scientific

discoveries into practice and policy, and to reduce injuries, violence and related disabilities.

(Faculty Investigator)

2016-18 Department of Population Medicine Faculty Grant, Harvard Medical School and Harvard Pilgrim

Health Care Institute (Wagner – PI)

Addressing Payers' Challenges in Managing Novel Cancer Therapy Coverage

(Co-Investigator/Consultant)

Rebecca L. Haffajee, Page 6

2016-17 Centers for Disease Control & Prevention, Injury Control Prevention Centers (ICPC) Thematic

Network, University of Michigan Injury Prevention Center

Addressing Opioid Misuse, Abuse, and Overdose: Project coordinates work across four CDC-funded

ICPCs and disseminates evidence-based recommendations for addressing the opioid epidemic.

(Co-Investigator)

2015-16 Graduate School of Arts and Sciences, Harvard University (Dissertation Completion Grant)

Evaluating Legal Interventions Designed to Improve Behavioral Health Outcomes

2014-15 Department of Population Medicine Thomas O. Pyle Fellowship Grant, Harvard Medical School and

Harvard Pilgrim Health Care Institute

Impact of Prescription Drug Monitoring Programs on Prescribing and Abuse of Prescription Drugs

2013-14 Department of Population Medicine Thomas O. Pyle Fellowship Grant, Harvard Medical School and

Harvard Pilgrim Health Care Institute

Impact of Mental Health Parity Laws on Mental Health Treatment and Outcomes

2013-14 Public Health Law Research Program Strategic and Targeted Research Program, Robert Wood

Johnson Foundation (Dissertation Grant)

Impact of Mental Health Parity Laws on Mental Health Treatment and Outcomes

2013-14 National Institute of Mental Health (Health Policy Training Grant)

Evaluating Legal Interventions Designed to Improve Behavioral Health Outcomes

2012-13 Department of Population Medicine Pharmaceutical Policy Research Fellowship Grant, Harvard

Medical School and Harvard Pilgrim Health Care Institute

Impacts of Mental Health Parity Laws Designed to Increase Access to Care and Treatment

TEACHING EXPERIENCE:

2017-19 Law and Public Health. Health Management and Policy Department, University of Michigan School

of Public Health & University of Michigan Law School. Lead Instructor. Designed and taught course

curriculum.

2017-18 Calling Bullshit. Health Management and Policy Department, University of Michigan School of

Public Health. Co-Instructor. Co-taught with Professors Scott Greer, Edward Norton, and Jeffrey

McCullough seminar on identifying, addressing, and considering the ethical implications of

“bullshit” in health services and health policy research.

2017 Program Evaluation. Health Management and Policy Department, University of Michigan School of

Public Health. Lead Instructor. Coordinated and co-taught with Professors Daniel Eisenberg and Neil

Mehta seminar on methods for program evaluation in public health.

2013-14 Core Course in Health Policy. Graduate School of Arts and Sciences, Harvard University. Teaching

Fellow to Professors Joseph Newhouse and Alan Zaslavsky.

2012 Public Health Law. Harvard School of Public Health. Teaching Assistant to Professor Michelle

Mello.

2011 Empirical and Mathematical Reasoning 20: The Business and Politics of Health. Faculty of Arts and

Sciences, Harvard University. Head Teaching Fellow to Professor David Cutler.

2010 International Women’s Human Rights Clinic. Georgetown University Law Center. Co-Instructor

(included a clinical trip to Namibia).

2009-10 International Health Regulations. World Health Organization. Head Instructor and Course

Coordinator (on behalf of Georgetown University Law Center) for legal components of the

International Health Regulations.

2006 Making Rights Real: The Ghana Project. Harvard Law School. Clinical Teaching Assistant to

Professor Lucie White (included a clinical trip to Ghana).

Rebecca L. Haffajee, Page 7

2001 Computer Science 4: Introduction to Programming. Duke University. Teaching Assistant to

Professor Dietolf Ramm.

1999-2000 SAT Math. The Princeton Review. Course Instructor and Tutor.

DOCTORAL STUDENT ADVISING:

Charley Willison, MPH, MA – PhD in Health Services, Organization and Policy, University of Michigan (2019)

Tarlise Townsend, MPH – PhD in Health Services, Organization and Policy & PhD in Sociology, University of

Michigan (anticipated 2021)

Amanda Mauri, MPH – PhD in Health Services, Organization and Policy, University of Michigan (anticipated

2022)

Cecelia French, MPH – PhD in Human Behavior and Health Education, University of Michigan (anticipated 2022)

BIBLIOGRAPHY:

ARTICLES:

1. Haffajee RL. The public health value of opioid litigation. J L Med Ethics 2020 (forthcoming).

2. Maust DT, Lin LA, Goldstick JE, Haffajee RL, Brownlee R, Bohnert ASB. Association of Medicare Part

D benzodiazepine coverage expansion and changes in fall-related injury and overdoses among Medicare

Advantage beneficiaries. JAMA Netw Open 2020: in press.

3. Haffajee RL, Cherney S, Smart R. Legal requirements and recommendations to prescribe naloxone. Drug

& Alc Depend 2020;209:107896.

4. Haffajee RL, Frank RG. Abuses of FDA regulatory procedures — the case of Suboxone. N Eng J Med

2020;382(6):496-498. PMID: 31914238

5. Haffajee RL, Abrams MR. Settling the score: maximizing the public health impact of opioid litigation.

Ohio St Law J 2020; 80(4):701-740 (ranked 41/948 U.S. law journals).

6. Haffajee RL, Frank RG. Generic drug policy and Suboxone® to treat opioid use disorder. J L Med Ethics

2019;47(S4):43-53. PMID: 31955697

7. Mauri AM, Townsend T, Haffajee RL. The association of state opioid misuse prevention policies with

patient‐ and provider‐related outcomes: a scoping review. Millbank Q 2019 Dec. 4 2019. PMID:

31800142

8. Agarwal S, Bryan JD, Hu HM, Lee JS, Chua KP, Haffajee RL, Brummett CM, Englesbe MJ, Waljee JF.

Association of state opioid duration limits with postoperative opioid prescribing. JAMA Netw Open Dec.

2;2(12):e1918361. PMID: 31880801

9. Haffajee RL. Prescription drug monitoring programs: friend or folly in addressing the opioid-overdose

crisis? N Eng J Med 2019;381:699-701. PMID: 31433916

10. Lagisetty PA, Lin LA, Ganoczy D, Haffajee RL, Bohnert ASB. Opioid prescribing after opioid-related

inpatient hospitalizations by diagnosis: a cohort study. Med Care 2019;57(10):815-821. PMCID:

PMC6742521

Rebecca L. Haffajee, Page 8

11. Haffajee RL, Lin LA, Bohnert ASB, Goldstick JE. Characteristics of U.S. counties with high opioid

overdose mortality and low capacity to deliver medications for opioid use disorder. JAMA Netw Open

2019;2(6):e196373. PMCID: PMC6604101

12. Haffajee RL, Mello MM, Zhang F, Busch AB, Zaslavsky AM, Wharam JF. Association of federal

mental health parity legislation with health care use and spending among high utilizers of services. Med

Care 2019;57(4):245-255. PMCID: PMC6423539

13. Haffajee RL, French CA. Provider perceptions of system-level opioid prescribing and addiction

treatment policies. Curr Opin Psychol 2019;30:65-73. PMID: 30856591

14. Chua KP, Brummett CM, Conti R, Haffajee RL, Prosser L, Bohnert ASB. Assessment of prescriber and

pharmacy shopping among the family members of patients prescribed opioids. JAMA Netw Open

2019;2(5):e193673. PMCID: PMC6512276

15. Boehnke KF, Gangopadhyay S, Clauw DJ, Haffajee RL. Qualifying conditions of medical cannabis

license holders in the United States. Health Aff 2019;38(2):295-302. PMCID: PMC6398594

16. Yang TY, Weintraub E, Haffajee RL. Telemedicine’s role in addressing the opioid crisis. Mayo Clin

Proc. 2018;93(9):1177-1180. PMCID: PMC6330237

17. Kennedy-Hendricks A, Epstein AJ, Stuart EA, Haffajee RL, McGinty EE, Busch AB, Huskamp H, Barry

CL. Federal parity and spending for mental illness. Pediatrics 2018;142(2):e20172618. PMID:25726986

18. Haffajee RL, MacCoun RJ, Mello MM. Behind schedule—reconciling federal and state marijuana

policy. N Engl J Med 2018;379(6):501-504. PMID: 29996065

19. Haffajee RL, Mello MM, Zhang F, Zaslavsky AM, Larochelle MR, Wharam JF. Four states with robust

prescription drug monitoring programs reduced opioid dosages. Health Aff 2018;37(6):964-74. PMCID:

PMC6298032

20. Haffajee RL, Bohnert ASB, Lagisetty PA. Policy pathways to address workforce barriers to

buprenorphine treatment. Am J Prev Med 2018;54(6):S230-S242. PMCID: PMC6330240

21. Haffajee RL, Frank RG. Making the opioid public health emergency effective. JAMA Psych

2018;75(8):767-768. PMCID: PMC6378105

22. Haffajee RL, Mello MM. Drug companies’ liability for the opioid epidemic. N Engl J Med

2017;377(24):2301-2305. PMID: 29236640

23. Yang TY, Larochelle MR, Haffajee RL. Managing increasing liability risks related to opioid prescribing.

Am J Med 2017;130(3):249-50. PMID: 27644150

24. Yang TY, Haffajee RL. Murder liability for prescribing opioids: a way forward? Mayo Clin Proc 2016;

91(10):1331-35. PMID: 27502463

25. Haffajee RL. Preventing opioid misuse with prescription drug monitoring programs: a framework for

evaluating the success of state public health laws. Hastings Law J 2016; 67(6):1621-1694 (ranked 34/948

U.S. law journals).

26. Haffajee RL, Jena AB, Weiner SG. Mandatory use of prescription drug monitoring programs. JAMA

2015;313(9):891-892. PMCID: PMC4465450

Rebecca L. Haffajee, Page 9

27. Haffajee RL, Parmet WE, Mello MM. What is a public health “emergency”? N Engl J Med

2014;371(11):986-988. PMID: 25207765

28. Haffajee RL, Bloche GM. The FCTC and the psychology of tobacco control. Asian J WTO Int’l Health

Law & Pol’y 2010;5(1): 87-113 (ranked 720/1537 U.S. & international law journals).

29. Haffajee RL. The potential use of joint criminal enterprise theory in prosecuting crimes of rape and

sexual violence at the ICTR. Harvard J Law & Gender 2006;29(1):201-221 (ranked 85/948 U.S. law

journals).

30. Haffajee RL. Genetic discrimination legislation in Massachusetts. GeneWatch 2000;13(5/6).

31. Haffajee RL. Medicare prescription drug benefits tug of war. Capital Eye 2001;8:5.

UNDER REVIEW:

1. Dora-Laskey A, Arterberry B, Roberts SJ, Haffajee RL, Bohnert ASB, Carter P, Goldstick J. Prevalence

and predictors of driving after prescription opioid use in an adult emergency department sample.

2. Haffajee RL, Andraka-Christou B, Dormond M, Cupito A, Buche J. Implementation challenges related

to medication-assisted treatment: a mixed methods study.

3. Leopold C, Haffajee RL, Lu CY, Wagner AK. The complex cancer care coverage environment – what is

the role of legislation? A case study from Massachusetts.

4. Haffajee RL, Goldstick JE, Bohnert ASB, Myers M, Boehnke K. Association between county-level

medical cannabis registrations and opioid-related overdose deaths.

OTHER:

1. Haffajee RL, Stein B. Spending the opioid settlement most effectively. Pitt Gazette. Dec. 19, 2019.

https://www.post-gazette.com/opinion/Op-Ed/2019/12/19/Rebecca-Haffajee-Bradley-Stein-Spending-the-

opioid-settlement-most-effectively/stories/201912190053

2. Harbraugh C, Malani P, Haffajee RL, Waljee JF. The culture of pain: perceptions of opioid-related

policy among U.S. older adults. Health Aff Blog, Apr. 17, 2019. Available at:

https://www.healthaffairs.org/do/10.1377/hblog20190415.123669/full/.

3. Boehnke KF, Haffajee RL. Medical Cannabis and Pain: The Author’s Reply. Health Aff 2019;38(4):694.

4. Boehnke KF, Clauw DJ, Haffajee RL. Letter to the editor: on chronic pain as a qualifying condition for

medical cannabis licenses. Health Aff 2019 (forthcoming).

5. Frank RG, Haffajee RL. Generic drug policy and opioid use disorder treatment. Laura and John Arnold

Foundation: White Paper, Jan. 2019.

6. Frank RG, Haffajee RL. The Trump administration’s actions to solve the opioids public health crisis: a

reply. JAMA Psych. Oct. 31, 2018. doi:10.1001/jamapsychiatry.2018.2761

7. Atterman J, Dormand J, Schreiber J, Haffajee RL, et al. Behavioral health workforce challenges related

to medication assisted treatment. Behavioral Health Workforce Research Center, University of Michigan.

Jan. 2018. Available at: http://www.behavioralhealthworkforce.org/wp-

content/uploads/2018/04/Y2FA3P2_MAT-Full-Report.pdf.

Rebecca L. Haffajee, Page 10

8. Haffajee RL. Will public health litigation help to solve the opioid crisis? Public Health Law Watch Blog.

Dec. 21, 2017. Available at: https://www.publichealthlawwatch.org/blog/2017/12/22/will-public-health-

litigation-help-to-solve-the-opioid-crisis?rq=haffajee.

9. Haffajee RL, Liber AC, Warner KE. A safer way to legalize marijuana. Health Affairs Blog, Sept. 8,

2017. Available at: https://www.healthaffairs.org/do/10.1377/hblog20170908.061869/full/.

10. Carter P, Abir M, Bohnert ASB, Cunningham RC, Dora-Laskey A, Haffajee RL, Martin J, Walton M.

The prescription opioid epidemic in Michigan: evidence, expertise, and recommendations for action.

University of Michigan Injury Center. Sept. 2017.

11. Haffajee RL. Fight the urge to criminalize opioid addiction behaviors. Health Affairs Blog, March 9,

2016. Available at: http://healthaffairs.org/blog/2016/03/09/fight-the-urge-to-criminalize-opioid-

addiction-behaviors/.

12. Haffajee RL. Widespread use of prescription drug monitoring programs to reduce opioid abuse and

overdoses. Bill of Health Blog, Harvard Law School / Petrie Flom Center for Health Law Policy

Biotechnology, and Bioethics. Mar. 9, 2015. Available at:

http://blogs.harvard.edu/billofhealth/2015/03/09/widespread-use-of-prescription-drug-monitoring-

programs-to-reduce-opioid-abuse-and-overdoses/.

13. Haffajee RL. What is (or isn’t) a public health “emergency”? Bill of Health Blog, Harvard Law School

Petrie Flom Center for Health Law Policy Biotechnology, and Bioethics. Sept. 12, 2014. Available at:

http://blogs.harvard.edu/billofhealth/2014/09/12/what-is-or-isnt-a-public-health-emergency/.

14. Haffajee RL. Soda industry sues to block NYC ban on sugar-sweetened beverage sales. Bill of Health

Blog, Harvard Law School / Petrie Flom Center for Health Law Policy Biotechnology, and Bioethics.

Oct. 15, 2012. Available at: http://blogs.harvard.edu/billofhealth/2012/10/15/soda-industry-sues-to-block-

nyc-ban-on-soda-sales/.

15. Haffajee RL. What do we know about obesity and its prevention in the U.S. Bill of Health Blog, Harvard

Law School / Petrie Flom Center for Health Law Policy Biotechnology, and Bioethics. Oct. 5, 2012.

Available at: http://blogs.harvard.edu/billofhealth/2012/10/05/what-do-we-know-about-obesity-and-its-

prevention-in-the-u-s/.

16. Haffajee RL. MA health reform and medical debt – getting the facts straight. Bill of Health Blog,

Harvard Law School / Petrie Flom Center for Health Law Policy Biotechnology, and Bioethics. Sept. 12,

2012. Available at: http://blogs.harvard.edu/billofhealth/2012/09/12/ma-health-reform-and-medical-debt-

getting-the-facts-straight/.

UNDER PREPARATION:

1. Haffajee RL, Mello MM, Myers M, Larochelle MR, Cunningham RC, Goldstick JE, Bohnert ASB.

Trends in and predictors of state-level opioid misuse and overdose prevention policy adoption.

2. Haffajee RL, Bohnert ASB, Mello MM, Myers M, Goldstick JE, Larochelle MR. Association between

Medicaid expansion and opioid-related overdose deaths.

3. Haffajee RL, Mello MM, Larochelle MR, Myers MG, Bohnert ASB. Association between state-level

opioid misuse and overdose prevention policies and opioid-related prescribing and nonfatal overdose

outcomes.

Rebecca L. Haffajee, Page 11

SELECTED MEDIA:

1. “States of emergency,” Work cited by Nicholas Bagley for The Incidental Economist. Sept. 12, 2014.

Available at: https://theincidentaleconomist.com/wordpress/states-of-emergency/.

2. “Rise in prescription drug overdose deaths is slowing. Do monitoring programs deserve credit?”

Interview for Sound Medicine Radio. Feb. 27, 2015. Available at: http://soundmedicine.org/post/rise-

prescription-drug-overdose-deaths-slowing-do-monitoring-programs-deserve-credit.

3. “Tackling prescription drug abuse,” Interview with Brian Owens for The Pharmaceutical Journal. June

11, 2015. Available at: https://www.pharmaceutical-journal.com/news-and-analysis/features/tackling-

prescription-drug-abuse/20068685.article.

4. “Prescription tracking tackles misuse of opioids and other drugs – but results vary,” Interview with Kara

Gavin for Michigan Medicine. July 20, 2017. Available at: http://ihpi.umich.edu/news/prescription-

tracking-tackles-misuse-opioids-other-drugs-%E2%80%94-results-vary.

5. “Forced sterilization won’t fix the drug crisis,” Interview with S.E. Smith for Rewire. Aug. 3, 2017.

Available at: https://rewire.news/article/2017/08/03/forced-sterilization-wont-fix-drug-crisis/.

6. “What would happen if Trump declared the opioid epidemic a national emergency,” Interview with

Francie Diep for Pacific Standard. Aug. 4, 2017. Available at: https://psmag.com/news/what-would-

happen-if-trump-declared-opioid-epidemic-national-emergency.

7. “Trump is declaring opioid addiction a national emergency after all,” Interview with Francie Diep for

Pacific Standard. Aug. 10, 2017. Available at: https://psmag.com/news/trump-declares-opioid-addiction-

a-national-emergency.

8. “Legalizing marijuana should not include smoked form, say U-M experts,” Interview with/and article

referenced by Laurel Thomas for Michigan News, Association of Schools and Programs for Public

Health. Sept. 8, 2017. Available at: https://news.umich.edu/legalizing-marijuana-should-not-include-

smoked-form-say-u-m-experts/.

9. “What do Harvey and Irma mean for America’s opioid emergency,” Interview with Francie Diep for

Pacific Standard. Sep. 13, 2017. Available at: https://psmag.com/social-justice/what-do-harvey-and-irma-

mean-for-americas-opioid-emergency.

10. “Trump says he's going to declare the opioid crisis a national emergency. Here's what that means,”

Interview with Jeffrey Cook for ABC News. Oct. 23, 2017. Available at:

http://abcnews.go.com/Politics/trump-declare-opioid-crisis-national-emergency-

means/story?id=50618305.

11. “U.S. national emergency declaration for the opioid crisis,” Interview with David Whitty for BBC World

Service Radio. Oct. 25, 2017.

12. “Trump’s emergency declaration on opioid crisis will require further funding,” Interview with Vivian

Salama for NBC News. Oct. 26, 2017. Available at: https://www.nbcnews.com/storyline/americas-heroin-

epidemic/trump-s-emergency-declaration-opioid-crisis-will-require-further-funding-n814416.

13. “Tackling the opioid epidemic: Using alternative therapies and new technologies to curb a national

crisis,” Interview with Andrea LaFerle for Findings Magazine. Oct. 26, 2017. Available at:

https://sph.umich.edu/news/home-releases/tackling-opioids-102517.html.

Rebecca L. Haffajee, Page 12

14. “Opioids,” Interview with John Otrompke for Burroughs Healthcare Consulting Network. Oct. 27, 2017.

Available at: https://burroughshealthcare.com/2017/10/27/opioid-epidemic-a-multi-factorial-solution-

including-drug-price-negotiation-and-interstate-prescription-monitoring/.

15. “Teach-out focusing on opioid epidemic starts Dec. 4,” Interview with Laurel Thomas for The University

Record. Nov. 22, 2017. Available at: http://record.umich.edu/articles/u-m-teach-out-focusing-opioid-

epidemic-starts-dec-4.

16. “Opioid epidemic weighing heavy on local governments: new strategies planned to combat drugs,”

Quoted by Matthew Smith for WXYZ Detroit. Nov. 29, 2017. Available at:

https://www.wxyz.com/news/opioid-epidemic-weighing-heavy-on-local-governments.

17. “Interview with Dr. Rebecca Haffajee on the growing number of lawsuits against opioid manufacturers and

distributors,” New England Journal of Medicine. Dec. 14, 2017. Available at:

http://www.nejm.org/action/showMediaPlayer?doi=10.1056%2FNEJMp1710756&aid=NEJMp1710756_

attach_1&area=.

18. “Drug overdose deaths continue to soar,” Article referenced by Steve Sternberg for U.S. News & World

Reports. Dec. 15, 2017. Available at: https://www.usnews.com/news/national-news/articles/2017-12-

15/drug-overdose-deaths-continue-to-soar.

19. “Going after opioid manufacturers, distributors in court may help crisis,” Interview with Laurel Thomas

for The University Record, Association of American Universities. Dec. 13-18, 2017. Available at:

http://record.umich.edu/articles/going-after-opioid-manufacturers-distributors-court-may-help-crisis.

20. “To fight the opioid epidemic, take drug makers to court?” Interview with Laurel Thomas for Futurity.

Dec. 19, 2018. Available at: https://www.futurity.org/suing-opioid-manufacturers-1635662/.

21. “In the fight against the opioid epidemic, lawsuits could be a useful tool,” Interview with April Van

Buren for Michigan Radio, NPR News Station. Dec. 18, 2017. Available at:

http://michiganradio.org/post/fight-against-opioid-epidemic-lawsuits-could-be-useful-tool.

22. “Lansing sues drug companies over opioid epidemic,” Interview with Sarah Lehr for Lansing State

Journal. Dec. 19, 2017. Available at:

https://www.lansingstatejournal.com/story/news/2017/12/19/lansing-sues-drug-companies-over-opioid-

epidemic/964003001/.

23. “New legal approaches may compel drug companies to pay for opioid crisis,” Article referenced by Steve

Dubb for Nonprofit Quarterly. Dec. 20, 2018. Available at:

https://nonprofitquarterly.org/2017/12/20/new-legal-approaches-may-compel-drug-companies-pay-

opioid-crisis/.

24. “Ron Johnson uses altered data to blame opioid crisis on Medicaid,” Interview with Amanda Gomez for

Think Progress. Jan. 17, 2018. Available at: https://thinkprogress.org/misleading-data-opioid-crisis-

medicaid-e34e3f354b8e/.

25. “Opioid emergency declarations offer short-term benefit on a ‘slippery slope,’” Interview with Ryan

McDonald for Healio. Jan. 19, 2018. Available at: https://www.healio.com/hematology-

oncology/practice-management/news/online/%7B4463e79d-f79e-4a1b-809b-f0b06cebc500%7D/opioid-

emergency-declarations-offer-short-term-benefit-on-a-slippery-slope.

Rebecca L. Haffajee, Page 13

26. “The Sackler family made billions from OxyContin. Why do top US colleges take money tainted by the

opioid crisis?” Article referenced by Steve Dubb and Amy Costello in The Guardian. Jan. 27, 2018.

Available at: https://www.theguardian.com/us-news/2018/jan/27/universities-sackler-family-purdue-

pharma-oxycontin-opioids.

27. “Baltimore sues opioid manufacturers, distributors and a local doctor’s office over pain pills,” Interview

with Ian Duncan for The Baltimore Sun. Jan. 31, 2018. Available at:

http://www.baltimoresun.com/news/maryland/baltimore-city/bs-md-ci-city-opioid-suit-20180131-

story.html.

28. “How effective are opioid lawsuits?” Interview with Reuben Jones for Spectrum News. Feb. 1, 2018.

Available at: http://spectrumlocalnews.com/nc/charlotte/news/2018/02/01/opioid-crisis-lawsuits--are-

they-effective-.

29. “Council seeks steps vs. opioid makers and Holyoke Mayor Alex Morse considering ‘taking action,”

Article referenced by Mike Plaisance in MLive. Feb. 11, 2018. Available at:

http://www.masslive.com/news/index.ssf/2018/02/council_seeks_action_vs_opioid.html.

30. “Purdue Pharma cease promotion of OxyContin to doctors,” Interview with Andy Polhamus for Healio.

Feb. 13, 2018. Available at: https://www.healio.com/hematology-oncology/practice-

management/news/online/%7Bf449c490-270b-4d7f-961b-7d42f2334ed1%7D/purdue-pharma-ceases-

promotion-of-oxycontin-to-doctors.

31. “A south Texas county drags PBMs into nationwide lawsuit over opioids,” Interview with Casey Ross for

STAT. Feb. 26, 2018. Available at: https://www.statnews.com/2018/02/26/texas-pbm-opioid-

lawsuit/?utm_source=STAT+Newsletters&utm_campaign=53fc2df257-

Daily_Recap&utm_medium=email&utm_term=0_8cab1d7961-53fc2df257-150070213.

32. “Pharmacy benefits managers in crosshairs of latest opioid lawsuit,” Quoted by Marlene Satter for

Benefitspro. Feb. 26, 2018. Available at: https://www.benefitspro.com/2018/02/26/pharmacy-benefits-

managers-in-crosshairs-of-latest/.

33. “Justice Department to join wave of state, city lawsuits against opioid makers, Sessions says,” Interview

with Jon Schuppe for NBC News. Feb. 27, 2018. Available at: https://www.nbcnews.com/news/us-

news/justice-department-join-wave-state-lawsuits-against-opioid-makers-sessions-n851721.

34. “Opioid lawsuit places blame of pharmacy benefit managers,” Quoted by Laurie Toich for The American

Journal of Pharmacy Benefits. Mar. 1, 2018. Available at: https://www.ajpb.com/news/opioid-lawsuit-

places-blame-on-pharmacy-benefit-managers.

35. “From pills to pot: The future of medical marijuana in Ohio,” Interview with Amanda Fay for WTOL 11.

Mar. 9, 2018. Available at: http://www.wtol.com/story/37686440/from-pills-to-pot-the-future-of-medical-

marijuana-in-ohio.

36. “Q&A: Holding drugmakers accountable for the opioid crisis,” Interview with Associated Press published

by The New York Times, The Washington Post, ABC News, NBC News, Yahoo, San Francisco Chronicle.

March 18, 2018. Available at: https://www.nytimes.com/aponline/2018/03/18/business/ap-us-insider-qa-

opioid-lawsuits.html.

37. “Opioid solutions promotes collaborative approach to the epidemic,” Work referenced by Alex Piazza for

The University Record. Apr. 18, 2018. Available at: http://record.umich.edu/articles/opioid-solutions-

promotes-collaborative-approach-epidemic.

Rebecca L. Haffajee, Page 14

38. “Opioid epidemic: more funding needed,” Interview with/article referenced by Nardy Baeza Bickel for

Michigan News, Medical Xpress, Association of Schools and Programs of Public Health. Apr. 26, 2018.

Available at: http://ns.umich.edu/new/releases/25603-opioid-epidemic-more-funding-needed;

https://medicalxpress.com/news/2018-04-resources-combat-opioid-epidemic.html.

39. “Experts suggest Trump declare opioid epidemic a ‘national emergency’,” Work referenced by Healio

Psychiatric Annals. May 1, 2018. Available at:

https://www.healio.com/psychiatry/addiction/news/online/%7Bf85ce7ef-874c-426e-87ee-

9447023ff831%7D/experts-suggest-trump-declare-opioid-epidemic-a-national-emergency.

40. “Lawmakers to grill drug wholesalers over opioid epidemic,” Interviewed by Dan Gorenstein for

Marketplace (Public Radio Program). May 8, 2018. Available at:

https://www.marketplace.org/2018/05/08/health-care/lawmakers-grill-drug-wholesalers-over-opioid-

epidemic.

41. “More funding needed to quash the opioid crisis in the US,” Work cited by Scott Repholz for Lifenism.

May 12, 2018. Available at: http://lifeinism.com/2018/05/12/more-funding-is-needed-to-quash-the-

opioid-crisis-in-the-us/.

42. “Michigan: policy considerations for addressing opioid crisis workforce needs and overcoming barriers to

provision of buprenorphine,” Work cited by Association of Schools & Programs of Public Health. May

15, 2018. Available at: https://www.aspph.org/michigan-policy-considerations-for-addressing-opioid-

crisis-workforce-needs-and-overcoming-barriers-to-provision-of-buprenorphine/.

43. “Behavioral health workforce faces critical challenges in meeting population needs,” Interviewed by

American Journal of Preventive Medicine regarding press release for Special Supplement article for

EurekAlert, Medical Xpress, AlphaGalileo, Science Daily. May 17, 2018. Available at:

https://www.eurekalert.org/pub_releases/2018-05/e-bhw051518.php.

44. “Hold them to account: Pittsburgh joins a broad suit against drug industry,” Work referenced by The

Editorial Board for Pittsburgh Post-Gazette. May 17, 2018. Available at: http://www.post-

gazette.com/opinion/editorials/2018/05/17/Hold-them-to-account-Pittsburgh-joins-a-broad-suit-against-

drug-industry/stories/201805170046.

45. “Stein right to go after drug firms as a major part of opioid abuse plague.” Work cited by the Capitol

Broadcasting Company Editorial team. May 25, 2018. Available at: https://www.wral.com/editorial-stein-

is-right-to-go-after-drug-firms-as-a-major-part-of-the-opioid-abuse-plague/17579067/.

46. “Bolingbrook backs national opioid lawsuit,” Work cited by Grace Tucker for Bugle News. June 7, 2018.

Available at: https://buglenewspapers.com/bolingbrook-backs-national-opioid-lawsuit.

47. “County moves on opioid suit,” Work references by Don Reid for Coldwater Daily Reporter. June 14,

2018. Available at: http://www.thedailyreporter.com/news/20180614/county-moves-on-opioid-suit.

48. “All state opioid monitoring programs are not created equal,” Interviewed by Nardy Baeza-Bickel for

Michigan News, Medical Xpress, Association of Schools and Programs of Public Health. June 7, 2018.

Available at: https://medicalxpress.com/news/2018-06-state-opioid-equal.html.

49. “New study finds robust drug monitoring programs reduce over prescription,” Interviewed by Ben Thorp

for WCMU Public Radio. June 7, 2018. Available at: http://radio.wcmu.org/post/new-study-finds-robust-

drug-monitoring-programs-reduce-over-prescription.

Rebecca L. Haffajee, Page 15

50. “4 U.S. states beat all others at cutting opioid dosages,” Interviewed by Nardy Baeza-Bickel for

Michigan News, Futurity. June 18, 2018. Available at: https://www.futurity.org/opioids-state-programs-

cutting-dosage-1787402/.

51. “These 4 states saw the biggest drop in opioid prescriptions,” Work referenced by Harrison Cook for

Becker’s Hospital Review. June 19, 2018. Available at:

https://www.beckershospitalreview.com/opioids/these-4-states-saw-the-biggest-drop-in-opioid-

prescriptions.html.

52. “Behind schedule – reconciling federal and state marijuana policy,” Work cited by Douglas Berman for

Marijuana Law, Policy & Reform. July 13, 2018. Available at:

http://lawprofessors.typepad.com/marijuana_law/2018/07/behind-schedule-reconciling-federal-and-state-

marijuana-policy.html.

53. “Implications of the Divide between Federal and State Marijuana Policy,” Interviewed for Video by

University of Michigan School of Public Health. July 16, 2018. Available at:

https://youtu.be/lIUJDJ3p7ls.

54. “Sex, Drugs, and Civil Liberties,” Radio interview KOPN Columbia Missouri 89.5 FM show by host,

Dan Viets, to discuss state and federal marijuana policy. July 17, 2018.

55. “Mental health parity law associated with financial protection for children,” Work referenced by 2 Minute

Medicine. July 23, 2018. Available at: https://www.2minutemedicine.com/mental-health-parity-law-

associated-with-financial-protection-for-children/.

56. “Marijuana’s uncertain stats: closing the gap between state and federal policies,” Work cited by Laurel

Ranger for Medical Bag. Aug. 7, 2018. Available at: https://www.medicalbag.com/policy/state-federal-

marijuana-policy-gap/article/786479/.

57. “Interview with Dr. Rebecca Haffajee on reconciling federal and state marijuana policy,” New England

Journal of Medicine. Aug. 8, 2018. Available at: https://www.nejm.org/doi/full/10.1056/NEJMp1804408.

58. “Pot legalization advocates seek foothold in Midwest states,” Interview by David Eggert for Associated

Press article published in The New York Times, The Washington Post, U.S. News & World Report, The

Detroit News, Fox Business, ABC News, Houston Chronicle, Miami Herald, Chicago Tribune. Oct. 9,

2018. Available at https://www.nytimes.com/aponline/2018/10/09/us/ap-us-election-2018-

marijuana.html.

59. “One year after Trump declared opioid addiction a public-health emergency, what’s changed?”

Interviewed by Francie Diep for Pacific Standard. Oct. 25, 2018. Available at

https://psmag.com/news/one-year-after-trump-declared-opioid-addiction-a-public-health-emergency-

whats-changed.

60. “China has promised to crack down on fentanyl. Here’s what that could mean for overdose

deaths in the U.S.,” Interviewed by Jaimie Ducharme for Time, Dec. 3, 2018. Available at:

http://time.com/5469231/china-fentanyl-controlled-substance/.

61. “Impact of Michigan’s marijuana law,” Interviewed by Jorge Avellan for WEMU radio (National Public

Radio station), Dec. 6, 2018.

62. “What drives patients to use medical marijuana: Mostly chronic pain,” Work cited in Science Daily, Feb.

4, 2019. Available at: https://www.sciencedaily.com/releases/2019/02/190204172220.htm.

Rebecca L. Haffajee, Page 16

63. “Evidence for addressing the opioid epidemic: rounding out the evidence,” Work cited by Colleen Barry

and Richard Frank in Brookings Institution Blog, Feb. 6, 2019. Available at:

https://www.brookings.edu/blog/up-front/2019/02/06/evidence-for-addressing-the-opioid-epidemic-

rounding-out-the-picture/.

64. “What Oklahoma’s $270 million settlement with Purdue Pharma means for the 1,000-plus opioid cases

still pending,” Interviewed by Francie Diep for Pacific Standard. Mar. 27, 2019. Available at:

https://psmag.com/news/what-oklahomas-settlement-with-purdue-pharma-means-for-opioid-cases.

65. “Smoking pot vs. tobacco: What science says about lighting up,” Interviewed by Jennifer Peltz for

Associated Press article published in Chicago Tribune, Houston Chronicle, San Francisco Chronicle,

Washington Post, ABC News, Omaha-World Herald, NBC Chicago, U.S. News & World Report, The

Detroit News. April 7-8, 2019. Available at: https://www.chicagotribune.com/lifestyles/health/ct-cb-

smoking-pot-vs-tobacco-20190408-story.html.

66. “Don’t just blame drug companies for the opioid epidemic,” Presentation quoted by Joyce Friedan in

MedPage Today, April 14, 2019. Available at: https://www.healthleadersmedia.com/dont-just-blame-

drug-companies-opioid-crisis.

67. “University of Michigan and Harvard hold joint summit on opioid crisis,” Quoted by Jacob Hamilton in

MLive, May 10, 2019. Available at: https://www.mlive.com/news/ann-arbor/2019/05/university-of-

michigan-harvard-team-up-to-tackle-opioid-crisis.html.

68. “University of Michigan, Harvard team up to tackle opioid crisis,” Quoted by Martin Slagter in MLive, May 10,

2019. Available at: https://www.mlive.com/news/ann-arbor/2019/05/university-of-michigan-harvard-team-

up-to-tackle-opioid-crisis.html.

69. “Opioid doctor and pharmacy ‘shoppers’ may also shop at home, study suggests,” Work cited by Kara

Gavin in University of Michigan News, May 10, 2019. Available at: https://news.umich.edu/opioid-

doctor-and-pharmacy-shoppers-may-also-shop-at-home-u-m-study-suggests/.

70. “Responses To The Opioid Epidemic Vary Across The Country — But A Few Themes Stand Out,”

Interviewed by Celia Darrough & Paige Tartorelli for Bustle, June 5, 2019. Available at:

https://www.bustle.com/p/responses-to-the-opioid-epidemic-vary-across-the-country-but-a-few-themes-

stand-out-17939248.

71. “How an American billionaire predicted — and then profited from — an Oxycontin 'prescription

blizzard’,” Quoted by Adrianna Belmonte for Yahoo Finance, June 12, 2019. Available at:

https://finance.yahoo.com/news/opioid-crisis-purdue-sacklers-141623926.html.

72. “Opioids study shows high-risk counties across the country, suggests local solutions to epidemic,” Study

profiled by Nardy Baeza Bickel in University of Michigan News, June 28, 2019. Available at:

https://news.umich.edu/opioids-study-shows-high-risk-counties-across-the-country-suggests-local-

solutions-to-epidemic/.

73. “24 Michigan counties are at ‘high-risk’ in the national opioid epidemic,” Interviewed by Stateside Staff in

Michigan Radio National Public Radio, July 10, 2019. Available at: https://www.michiganradio.org/post/24-

michigan-counties-are-high-risk-national-opioid-epidemic.

74. “A graphic look at the opioid epidemic,” Interviewed by the Jefferson Exchange Team for Jefferson

Public Radio, July 11, 2019. Available at: https://www.ijpr.org/post/graphic-look-opioid-

epidemic#stream/0.

Rebecca L. Haffajee, Page 17

75. “Drug overdose deaths in the U.S. appear to be falling, CDC data show,” Interviewed by Mike Stobbe for

Associated Press article published in LA Times, New York Times, Washington Post, MarketWatch, U.S. News

& World Reports, Washington Times, Seattle Times, ABCnews, Yahoo News, Fox News, WebMD, etc. July

17, 2019. Available at: https://www.latimes.com/science/story/2019-07-17/us-drug-overdose-deaths-

falling.

76. “Federal government pledges millions for opioid crisis,” Quoted by the Canadian Press for CBC, July 17,

2019. Available at: https://www.cbc.ca/news/health/opioid-crisis-1.5215690.

77. “Livingston county at ‘high-risk’ for opioid overdoses, study says,” Study profiled by Sean Bradley for

Livingston Daily, July 17, 2019. Available at:

https://www.livingstondaily.com/story/news/local/community/livingston-county/2019/07/17/livingston-

county-high-risk-opioid-overdoses-study-says/1734891001/.

78. “Forty-one N.C. counties classified as ‘high-risk’ in new opioid study,” Interviewed by Yen Duong for

North Carolina Health News, July 23, 2019. Available at:

https://www.northcarolinahealthnews.org/2019/07/23/41-nc-high-risk-medication-assisted-treatment/.

79. “Why aren’t more people with opioid use disorder getting buprenorphine? 2 experts discuss ways to

expand access to this effective drug,” Interview with PEW Charitable Trusts, July 31, 2019. Available at:

https://www.pewtrusts.org/en/research-and-analysis/articles/2019/07/31/why-arent-more-people-with-

opioid-use-disorder-getting-buprenorphine.

80. “New details about Michigan’s opioid crisis: Billions of pills and aggressive suppliers,” Quoted by Julie Mack &

Scott Levin in MLive, Aug. 12, 2019. Available at: https://www.mlive.com/news/2019/08/new-details-about-

michigans-opioid-crisis-billions-of-pills-and-aggressive-suppliers.html

81. “Average Michigan opioid patient got 62-day supply in 2018. CDC standard is less than a week,” Quoted by Julie

Mack & Scott Levin in MLive, Aug. 18, 2019. Available at: https://www.mlive.com/news/2019/08/average-

michigan-opioid-patient-got-62-day-supply-in-2018-cdc-standard-is-less-than-a-week.html.

82. “Healthcare policy researcher: State PDMPs need to be tweaked to improve functionality, safeguard

privacy,” Work cited by Mark Hagland in Healthcare Innovation, Aug. 21, 2019. Available at:

https://www.hcinnovationgroup.com/policy-value-based-care/public-health/news/21093784/healthcare-

policy-researcher-state-pdmps-need-to-be-tweaked-to-improve-functionality-safeguard-privacy.

83. “Cannabis: A Silver Bullet for the Opioid Crisis?” Interviewed by Jaime Santa Cruz in CRx Magazine,

Fall 2019. Available at: https://www.crxmag.com/issues/2019/fall/cannabis-a-silver-bullet-for-the-opioid-

crisis.shtml.

84. “How States Are Holding Opioid Manufacturers and Distributors Accountable,” Interviewed for The

Takeaway for WNYC Studios (produced by Public Radio International and WGBH and WNYC Studios),

Sept. 11, 2019. Available at: https://www.wnycstudios.org/podcasts/takeaway/segments/opioid-crisis-

drug-manufacturers-and-distributors.

85. “The opioid epidemic reckoning is happening – kind of,” Interviewed by Adriana Belmonte for Yahoo

Finance, Sept. 11, 2019. Available at: https://finance.yahoo.com/news/opioid-settlement-sackler-

200905914.html.

86. “Purdue Pharma Bankruptcy: Did Kentucky Settle for Enough?” Interviewed by Phillip M. Bailey for

Louisville Courier Journal, Sept. 20, 2019.

Rebecca L. Haffajee, Page 18

87. “The (Human) Cost of Greed,” Interviewed by James Strachan for The Medicine Maker, Nov. 27, 2019.

https://themedicinemaker.com/business-regulation/the-human-cost-of-greed

88. “Opioid-treatment maker again accused of anti-competitive practices,” Interviewed by Marty Schladen

for The Columbus Dispatch, Jan. 9, 2020. https://www.dispatch.com/news/20200109/opioid-treatment-

maker-again-accused-of-anti-competitive-practices

89. “NEJM Perspective: Congress Needs to Help FDA Combat Procedural Abuses,” Quoted by Zachary

Brennan for Regulatory Focus, Jan. 9, 2020. https://www.raps.org/news-and-articles/news-

articles/2020/1/nejm-perspective-congress-needs-to-help-fda-comba

90. “FDA to Pull Nearly 250 ANDAs, Continues to Revamp OND,” Quoted by Alex Keown for BioSpace,

Jan. 10, 2020. https://www.biospace.com/article/fda-to-pull-nearly-250-andas-continues-to-revamp-ond/

SELECTED PRESENTATIONS:

2013 “Impact of Mental Health Parity Laws on Costs, Service Utilization, and Health Outcomes,” PhD in

Health Policy Research Seminar, Department of Health Care Policy, Harvard Medical School, Boston,

MA.

2014 “Impact of Parity Laws on Mental Health Treatment and Outcomes,” Robert Wood Johnson Foundation

Public Health Law Research Program Annual Meeting, Atlanta, GA. (podium presentation)

2014 “Impact of the 2008 Federal Parity Law on Mental Health Care Utilization,” Pharmaceutical Policy

Research Seminar, Harvard Medical School/Harvard Pilgrim Health Care Institute, Boston, MA.

2015 “Impact of Prescription Drug Monitoring Programs on Use and Abuse of Prescription Drugs,”

Pharmaceutical Policy Research Seminar, Harvard Medical School/Harvard Pilgrim Health Care

Institute, Boston, MA.

2015 “Prescription Drug Monitoring: Promise or Predicament,” Health Policy Grand Rounds Invited

Speaker, Lawrence Memorial Hospital Campus, Hallmark Health System, Lawrence, MA.

2015 “Impact of Federal Mental Health Parity on Mental Health Use and Spending,” Department of

Population Medicine Brown Bag Lunch Seminar, Harvard Medical School/Harvard Pilgrim Health

Care Institute, Boston, MA.

2015 “Impact of Federal Mental Health Parity on Mental Health Care Use and Spending,” AcademyHealth

Annual Research Meeting, Minneapolis, MN. (poster presentation)

2016 “Opioid Addiction: Legal and Public Health Responses,” Harvard Law School Petrie Flom Center for

Health Law Policy Biotechnology, and Bioethics Year in P/Review Conference, Cambridge, MA.

(podium presentation)

2016 “Empirical Health Law,” Harvard Law School Petrie Flom Center for Health Law Policy

Biotechnology, and Bioethics 10th Anniversary Conference, Cambridge, MA. (panelist)

2016 “Effects of Robust State Prescription Drug Monitoring Programs on Opioid Prescribing and Use,”

Pharmaceutical Policy Research Seminar, Harvard Medical School/Harvard Pilgrim Health Care

Institute, Boston, MA.

Rebecca L. Haffajee, Page 19

2016 “Effects of Robust State Prescription Drug Monitoring Programs on Opioid Prescribing and Use,” 39th

Annual ASLME Health Law Professors Conference, Boston University School of Law, Boston, MA.

(podium presentation)

2016 “Evaluating Legal Interventions Designed to Improve Behavioral Health Outcomes,” PhD Program in

Health Policy Dissertation Defense, Harvard University, Boston, MA.

2016 “Evaluating Legal Interventions Designed to Improve Behavioral Health Outcomes,” Mental Health

Innovation, Services and Outcomes Program Invited Speaker, University of Michigan, Ann Arbor, MI.

2016 “The Opioid Epidemic: Origins and Policy Responses,” Griffith Leadership Center Virtual Alumni

Forum Invited Speaker, University of Michigan School of Public Health, Ann Arbor, MI.

2017 “The Effect of Robust Prescription Drug Monitoring Programs on Opioid Prescribing Outcomes,” 8th

Annual Empirical Health Law Conference, Boston University School of Law, Boston, MA. (podium

presentation)

2017 “Policy Strategies to Curb the Opioid Epidemic: The Role of Prescription Drug Monitoring Programs,”

Health Policy & Management Research Seminar Invited Speaker, Indiana University Fairbanks School

of Public Health, Indianapolis, IN.

2017 “Pandora’s Box: The (Unknown) Consequences of Legalizing Marijuana Use,” Law Students for

Sensible Drug Policy Seminar Invited Speaker, University of Michigan Law School, Ann Arbor, MI.

2017 “Using the Law to Ramp-Up Medication Assisted Treatment Therapy,” 40th Annual ASLME Health

Law Professors Conference, Georgia State University College of Law, Atlanta, GA. (podium

presentation)

2017 “The Effect of Robust Prescription Drug Monitoring Programs on Opioid Prescribing Outcomes,”

AcademyHealth Annual Research Meeting, New Orleans, LA. (podium presentation)

2017 “Prescription Drug Monitoring Programs: Policy Landscape & Best Practices,” Institute for Healthcare

Policy and Innovation & M-OPEN, Injury Prevention Center Event Invited Speaker, Ann Arbor, MI

2017 “The State of Michigan’s Opioid Epidemic: Origins and Impact,” Council of Michigan Foundations

Invited Speaker, Ann Arbor, MI.

2017 “The Effect of Robust Prescription Drug Monitoring Programs on Opioid Prescribing Outcomes,”

SAVIR Conference, Ann Arbor, MI. (podium presentation)

2017 “Policy Approaches to the Opioid Crisis,” USC-Brookings Schaeffer Initiative for Health Policy, The

Brookings Institution, Washington, DC. (panelist)

2018 “Monitoring and Regulating Prescribing to Mitigate the Opioid Epidemic,” The Institute for Continuing

Legal Education, 24th Annual Health Law Institute, Plymouth, MI. (podium presentation)

2018 “Using the Law to Tackle the Opioid Crisis,” Theodore R. LeBlang Distinguished Lectureship in Law

& Medicine, Southern Illinois University School of Medicine, Springfield, IL. (podium presentation)

2018 “Characterizing U.S. Counties with High Opioid Overdose and Low Medication-Assisted Treatment

Supply,” 41st Annual ASLME Health Law Professors Conference, Case Western Reserve University

School of Law, Cleveland, OH. (podium presentation)

Rebecca L. Haffajee, Page 20

2018 “Behavioral Health Workforce Implementation Challenges Related to Medication Assisted Treatment,”

AcademyHealth Annual Research Meeting, Seattle, WA. (poster presentation)

2018 “Characterizing U.S. Counties with High Opioid Overdose and Low Medication-Assisted Treatment

Supply,” AcademyHealth Annual Research Meeting, Seattle, WA. (poster presentation)

2018 “Characterizing U.S. Counties with High Opioid Overdose and Low Medication-Assisted Treatment

Supply,” AcademyHealth Annual Research Meeting, Behavioral Interest Group Meeting, Seattle, WA.

(podium presentation)

2018 “Building Successful Careers in Academia,” AcademyHealth Annual Research Meeting, Seattle, WA.

(podium presentation & panelist)

2018 “Emerging Approaches to Monitoring the Opioid Epidemic and its Impact,” AcademyHealth Annual

Research Meeting, Seattle, WA. (moderator)

2018 “Civil Drug Crisis in the United States,” Speaker at Facing Opioids Symposium, Ohio State Law

Journal Annual Symposium, Columbus, OH. (podium presentation & panelist)

2018 “Policy Approaches to Addressing the Opioid Crisis,” Keynote speaker, 2nd Annual Addiction

Conference, SUNY Upstate, Syracuse, NY. (podium presentation & panelist)

2018 “Opioid Prescribing Policy Impacts,” University of Michigan Dental School Invited Speaker, Ann

Arbor, MI. (podium presentation)

2018 “The Opioid Epidemic: States and Cities Strike Back,” Speaker/panelist for American Bar Association

Webinar. (presentation & panelist)

2019 “State Opioid Policy & Impacts,” Invited Speaker at Wolverine Caucus, Lansing, MI. (podium

presentation)

2019 “The Role of Litigation in Mitigating the Opioid Crisis,” 25th Annual Thomas Pitts Lectureship in

Medical Ethics, Medical University of South Carolina, Charleston, SC. (podium presentation &

panelist)

2019 “Public Policy & the Opioid Epidemic” Invited Speaker at American College of Physicians Internal

Medicine 2019 Annual Meeting, Philadelphia, PA. (podium presentation & panelist)

2019 “Opioids: Policy to Practice” Invited Speaker at University of Michigan/Harvard Summit, Ann Arbor,

MI. (panelist)

2019 “Generic Drug Policy as a Barrier to Opioid Use Disorder Treatment,” 42nd Annual ASLME Health

Law Professors Conference, Loyola University Chicago School of Law, Chicago, IL. (podium

presentation)

2019 “The Opioid Overdose Crisis: States and Localities Fight Back Using Litigation,” Michigania Faculty

Forum, Boyne City, MI. (podium presentation)

2019 “Public Health Law Approaches to Addressing the Opioid Crisis: Intended and Unintended

Consequences,” Michigania Faculty Forum, Boyne City, MI. (podium presentation)

2019 “Congressional Staff Briefing on Barriers to Substance Use Treatment,” Cannon House Office

Building, Washington, DC. (panelist)

Rebecca L. Haffajee, Page 21

2020 “Dying to Live: Halting Overdose Deaths,” South by Southwest Conference, Austin, TX. (panelist

speaker)

2020 “Using Litigation to Effectively Abate Opioid Health Harms,” Clifford Symposium, DePaul University

College of Law, Chicago, IL. (invited speaker)